Innovation & Technology in Gastroenterology and Hepatology Highlights from the 2018 ACG Annual Scientific Meeting

{This monograph is a product of the ACG Innovation & Technology (ad-hoc) Committee} Authors & Committee Members: Sarah Enslin, PA-C, Seth A Gross, MD, FACG; Aasma Shaukat, MD, MPH; Daniel Castaneda, MD, Drew Schembre, MD, Laith Jamil, ...

2018 Public Policy Year in Review: what did ACG do for you?

2018 Public Policy Year in Review:   What did ACG do for you?   Another look at last year’s important policy highlights. December November October September August July June May April March February January December ...

FDA Safety Communication: FDA Provides Interim Results of Duodenoscope Reprocessing Studies Conducted in Real-World Settings

Stephen B. Hanauer, MD, FACG Chair, ACG FDA Related Matters Committee On December 10, the U.S. Food & Drug Administration (FDA) released interim results from post-market surveillance studies on contamination rates with duodenoscopes after ...

Tri-Society Alert: GI Codes to Be Revalued after CMS Sides with Anthem; E/M Payment Changes Delayed

Late Thursday, November 1st, the Centers for Medicare & Medicaid Services (CMS) released the calendar year (CY) 2019 Medicare Physician Fee Schedule (PFS) final rule, which includes several significant policy and payment changes that are ...

Tri-Society Alert: GI Societies Applaud Long-Overdue Changes to ASC Annual Updates

On November 2, the Centers for Medicare and Medicaid Services (CMS) released the calendar year (CY) 2019 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. The administration ...

Trump Administration Seeking to Lower Costs for Medicare Part B Drugs

On Thursday, CMS announced a pre-regulation (“Advance Notice of Proposed Rulemaking”) seeking input on a new “International Pricing Index” (IPI) payment model related to the costs of drugs administered in physician practices and hospitals.  ...